FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3006627873> ?p ?o ?g. }

• W3006627873 endingPage "1251" @default.
• W3006627873 startingPage "1238" @default.
• W3006627873 abstract "microRNAs (miRNAs) are small non-coding RNAs acting as negative regulators of gene expression and involved in tumor progression. We recently showed that inhibition of the pro-metastatic miR-214 and simultaneous overexpression of its downstream player, the anti-metastatic miR-148b, strongly reduced metastasis formation. To explore the therapeutic potential of miR-148b, we generated a conjugated molecule aimed to target miR-148b expression selectively to tumor cells. Precisely, we linked miR-148b to GL21.T, an aptamer able to specifically bind to AXL, an oncogenic tyrosine kinase receptor highly expressed on cancer cells. Axl-148b conjugate was able to inhibit migration and invasion of AXL-positive, but not AXL-negative, cancer cells, demonstrating high efficacy and selectivity in vitro. In parallel, expression of ALCAM and ITGA5, two miR-148b direct targets, was reduced. More importantly, axl-148b chimeric aptamers were able to inhibit formation and growth of 3D-mammospheres, to induce necrosis and apoptosis of treated xenotransplants, as well as to block breast cancer and melanoma dissemination and metastatization in mice. Relevantly, axl aptamer acted as specific delivery tool for miR-148b, but it also actively contributed to inhibit metastasis formation, together with miR-148b. In conclusion, our data show that axl-148b conjugate is able to inhibit tumor progression in an axl- and miR-148b-dependent manner, suggesting its potential development as therapeutic molecule." @default.
• W3006627873 created "2020-02-24" @default.
• W3006627873 creator A5011750698 @default.
• W3006627873 creator A5012376450 @default.
• W3006627873 creator A5017728103 @default.
• W3006627873 creator A5019658090 @default.
• W3006627873 creator A5024927307 @default.
• W3006627873 creator A5032327963 @default.
• W3006627873 creator A5040676907 @default.
• W3006627873 creator A5046627942 @default.
• W3006627873 creator A5054632970 @default.
• W3006627873 creator A5064974581 @default.
• W3006627873 date "2020-01-01" @default.
• W3006627873 modified "2023-10-18" @default.
• W3006627873 title "Axl-148b chimeric aptamers inhibit breast cancer and melanoma progression" @default.
• W3006627873 cites W2002768720 @default.
• W3006627873 cites W2002961521 @default.
• W3006627873 cites W2004878973 @default.
• W3006627873 cites W2020086002 @default.
• W3006627873 cites W2024682947 @default.
• W3006627873 cites W2031019444 @default.
• W3006627873 cites W2034451546 @default.
• W3006627873 cites W2070407979 @default.
• W3006627873 cites W2073737788 @default.
• W3006627873 cites W2082833890 @default.
• W3006627873 cites W2083585231 @default.
• W3006627873 cites W2098302826 @default.
• W3006627873 cites W2103594573 @default.
• W3006627873 cites W2116908170 @default.
• W3006627873 cites W2117158801 @default.
• W3006627873 cites W2123175900 @default.
• W3006627873 cites W2123339548 @default.
• W3006627873 cites W2124213396 @default.
• W3006627873 cites W2135314242 @default.
• W3006627873 cites W2152513466 @default.
• W3006627873 cites W2155192875 @default.
• W3006627873 cites W2165200432 @default.
• W3006627873 cites W2223467128 @default.
• W3006627873 cites W2331897708 @default.
• W3006627873 cites W2398148463 @default.
• W3006627873 cites W2465519374 @default.
• W3006627873 cites W2496766335 @default.
• W3006627873 cites W2558790575 @default.
• W3006627873 cites W2570385339 @default.
• W3006627873 cites W2724192880 @default.
• W3006627873 cites W2740994733 @default.
• W3006627873 cites W2751551969 @default.
• W3006627873 cites W2770458596 @default.
• W3006627873 cites W2807813154 @default.
• W3006627873 cites W347868629 @default.
• W3006627873 doi "https://doi.org/10.7150/ijbs.39768" @default.
• W3006627873 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7053324" @default.
• W3006627873 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32174798" @default.
• W3006627873 hasPublicationYear "2020" @default.
• W3006627873 type Work @default.
• W3006627873 sameAs 3006627873 @default.
• W3006627873 citedByCount "16" @default.
• W3006627873 countsByYear W30066278732020 @default.
• W3006627873 countsByYear W30066278732021 @default.
• W3006627873 countsByYear W30066278732022 @default.
• W3006627873 countsByYear W30066278732023 @default.
• W3006627873 crossrefType "journal-article" @default.
• W3006627873 hasAuthorship W3006627873A5011750698 @default.
• W3006627873 hasAuthorship W3006627873A5012376450 @default.
• W3006627873 hasAuthorship W3006627873A5017728103 @default.
• W3006627873 hasAuthorship W3006627873A5019658090 @default.
• W3006627873 hasAuthorship W3006627873A5024927307 @default.
• W3006627873 hasAuthorship W3006627873A5032327963 @default.
• W3006627873 hasAuthorship W3006627873A5040676907 @default.
• W3006627873 hasAuthorship W3006627873A5046627942 @default.
• W3006627873 hasAuthorship W3006627873A5054632970 @default.
• W3006627873 hasAuthorship W3006627873A5064974581 @default.
• W3006627873 hasBestOaLocation W30066278731 @default.
• W3006627873 hasConcept C121608353 @default.
• W3006627873 hasConcept C126322002 @default.
• W3006627873 hasConcept C128972844 @default.
• W3006627873 hasConcept C153911025 @default.
• W3006627873 hasConcept C2777658100 @default.
• W3006627873 hasConcept C502942594 @default.
• W3006627873 hasConcept C530470458 @default.
• W3006627873 hasConcept C70721500 @default.
• W3006627873 hasConcept C71924100 @default.
• W3006627873 hasConcept C86803240 @default.
• W3006627873 hasConceptScore W3006627873C121608353 @default.
• W3006627873 hasConceptScore W3006627873C126322002 @default.
• W3006627873 hasConceptScore W3006627873C128972844 @default.
• W3006627873 hasConceptScore W3006627873C153911025 @default.
• W3006627873 hasConceptScore W3006627873C2777658100 @default.
• W3006627873 hasConceptScore W3006627873C502942594 @default.
• W3006627873 hasConceptScore W3006627873C530470458 @default.
• W3006627873 hasConceptScore W3006627873C70721500 @default.
• W3006627873 hasConceptScore W3006627873C71924100 @default.
• W3006627873 hasConceptScore W3006627873C86803240 @default.
• W3006627873 hasIssue "7" @default.
• W3006627873 hasLocation W30066278731 @default.
• W3006627873 hasLocation W30066278732 @default.
• W3006627873 hasLocation W30066278733 @default.
• W3006627873 hasLocation W30066278734 @default.

• next